Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novavax

7.44
+0.33004.64%
Volume:3.69M
Turnover:27.17M
Market Cap:1.21B
PE:3.59
High:7.53
Open:7.17
Low:7.09
Close:7.11
52wk High:11.55
52wk Low:5.01
Shares:162.50M
Float Shares:136.72M
Volume Ratio:0.69
T/O Rate:2.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.07
EPS(LYR):-1.2320
ROE:-898.20%
ROA:18.01%
PB:-7.72
PE(LYR):-6.04

Loading ...

Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
11 hours ago

Stock Track | Novavax Soars 5.06% as B. Riley Maintains Buy Rating Despite Lower Price Target

Stock Track
·
14 hours ago

Stock Track | Novavax Soars 5.06% Despite Price Target Cut as B. Riley Maintains Buy Rating

Stock Track
·
14 hours ago

Novavax price target lowered to $16 from $18 at B. Riley

TIPRANKS
·
Yesterday

Novavax Inc. Stock Slides 4.4%, Underperforms Peers

Dow Jones
·
Yesterday

B. Riley Adjusts Price Target on Novavax to $16 From $18, Maintains Buy Rating

MT Newswires Live
·
Nov 10

Novavax Inc : B. Riley Cuts Target Price to $16 From $18

THOMSON REUTERS
·
Nov 10

Assessing Novavax (NVAX) Valuation Following Q3 Revenue Beat and Expanded Sanofi Collaboration

Simply Wall St.
·
Nov 10

Novavax Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Nov 08

Novavax delays profitability target with eyes on Sanofi-led launches

Reuters
·
Nov 07

Novavax Exec Says Co Expects 2026 Adjusted Total Revenue Between $185 Million and $205 Million

THOMSON REUTERS
·
Nov 06

Novavax Exec Says Co Expects 2026-27 Season Nuvaxovid Royalties Will Grow Significantly as Compared to 2025 - Conf Call

THOMSON REUTERS
·
Nov 06

Earnings Flash (NVAX) Novavax Posts Q3 Net Loss $1.25 a Share, vs. FactSet Est of $1.20 Loss

MT Newswires Live
·
Nov 06

Stock Track | Novavax Soars 5.85% Pre-market on Better-than-Expected Q3 Results and Strong Revenue Outlook

Stock Track
·
Nov 06

Novavax Reports $70 Million Q3 Revenue and Raises 2025 Revenue Framework

Reuters
·
Nov 06

CORRECTED-UPDATE 3-Novavax defers profitability target by a year on weak COVID vaccine sales

Reuters
·
Nov 06

Novavax Outlook FY Adjusted Total Revenue USD 1,040-1,060 Million

THOMSON REUTERS
·
Nov 06

Novavax Outlook FY Adj Total Revenue $1.04 Bln-$1.06 Bln VS Ibes Estimate $1.05 Bln

THOMSON REUTERS
·
Nov 06

Novavax: Non-Cash Charges for Q3 Were $126 Mln

THOMSON REUTERS
·
Nov 06

Novavax beats quarterly revenue estimates on milestone payment

Reuters
·
Nov 06